Reaction
Urinary Sediment Present reporting signals
As of the last recalculation, Urinary Sediment Present appears in 633 FAERS reports alongside 14 co-occurring drug terms. The strongest observed disproportionality signal is ALEMTUZUMAB (PRR 500.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Alemtuzumab | 201 | 500.3 | 505.5 |
| Dimenhydrinate | 85 | 302.8 | 305.3 |
| Methylprednisolone Sodium Succinate | 72 | 57.4 | 57.5 |
| Methylprednisolone | 170 | 54.9 | 55.0 |
| Febuxostat Tablets 40 Mg | 13 | 42.9 | 42.9 |
| Febuxostat Tablets 80 Mg | 13 | 42.9 | 42.9 |
| Cetirizine Hydrochloride Allergy | 27 | 30.6 | 30.6 |
| Cetirizine Hydrochloride Tablets | 27 | 30.6 | 30.6 |
| Febuxostat | 13 | 26.0 | 26.0 |
| Ranitidine | 117 | 23.5 | 23.5 |
| Acyclovir | 66 | 21.1 | 21.1 |
| Tafamidis | 7 | 19.7 | 19.8 |
| Oxybutynin | 16 | 18.4 | 18.4 |
| Pazopanib Hydrochloride | 13 | 16.1 | 16.1 |